NTRA 9620
Alternative Names: NTRA-9620Latest Information Update: 01 Oct 2021
At a glance
- Originator Nutrinia
- Class Insulins
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Short bowel syndrome
Most Recent Events
- 01 Oct 2021 No development reported - Phase-II/III for Short bowel syndrome (In infants, In neonates) in Netherlands (PO)
- 01 Oct 2021 No development reported - Phase-II/III for Short bowel syndrome (In infants, In neonates) in USA (PO)
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Short-bowel-syndrome(In infants) in Israel (PO, Powder)